Page last updated: 2024-09-04

cyc 202 and Glial Cell Tumors

cyc 202 has been researched along with Glial Cell Tumors in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Babu, PP; Narne, P; Pandey, V; Ranjan, N1
Fernandez-Espinosa, DD; Isaja, L; Marazita, MC; Morris-Hanon, O; Romorini, L; Scassa, ME; Sevlever, GE; Videla-Richardson, GA1
Cardona-Gómez, GP; Palacio-Castañeda, V; Posada-Duque, RA1
Moir, RD; Myre, MA; Tanzi, RE; Tesco, G; Wasco, W; Washicosky, K1
Cruz, M; Siden, A; Tasat, DR; Vita, MF; Yakisich, JS1
Cai, XF; Hu, J; Yan, G1
Charron, E; Cheng, CK; Fan, QW; Goga, A; Gray, NS; Gustafson, WC; Houseman, BT; James, CD; Oakes, SA; Pollok, B; Shokat, KM; Weiss, WA; Zunder, E1
Choi, KS; Kim, EH; Kim, SU; Shin, DY1

Other Studies

8 other study(ies) available for cyc 202 and Glial Cell Tumors

ArticleYear
Roscovitine effectively enhances antitumor activity of temozolomide in vitro and in vivo mediated by increased autophagy and Caspase-3 dependent apoptosis.
    Scientific reports, 2019, 03-21, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Caspase 3; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Glioma; Humans; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Wistar; Roscovitine; Temozolomide; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2019
Palbociclib Effectively Halts Proliferation but Fails to Induce Senescence in Patient-Derived Glioma Stem Cells.
    Molecular neurobiology, 2019, Volume: 56, Issue:11

    Topics: Apoptosis; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Fibroblasts; Glioma; Humans; Neoplastic Stem Cells; Phenotype; Piperazines; Pyridines; Roscovitine

2019
CDK5 knockdown in astrocytes provide neuroprotection as a trophic source via Rac1.
    Molecular and cellular neurosciences, 2015, Volume: 68

    Topics: Animals; Animals, Newborn; Astrocytes; Cells, Cultured; Cerebral Cortex; Coculture Techniques; Cyclin-Dependent Kinase 5; Embryo, Mammalian; Excitatory Amino Acid Agonists; Glioma; Glutamic Acid; Mutation; Nerve Tissue Proteins; Neurons; Neuroprotection; Protein Kinase Inhibitors; Purines; rac1 GTP-Binding Protein; Rats; Rats, Wistar; rhoA GTP-Binding Protein; Roscovitine; Time Factors

2015
Reduced amyloidogenic processing of the amyloid beta-protein precursor by the small-molecule Differentiation Inducing Factor-1.
    Cellular signalling, 2009, Volume: 21, Issue:4

    Topics: Acetylcysteine; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Benzazepines; Cell Line; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Cyclin D1; Fibroblasts; Glioma; Hexanones; Humans; Hydrocarbons, Chlorinated; Indoles; Leupeptins; Mice; Peptide Fragments; Proteasome Inhibitors; Purines; Recombinant Fusion Proteins; Roscovitine; Threonine

2009
Strong inhibition of replicative DNA synthesis in the developing rat cerebral cortex and glioma cells by roscovitine.
    Investigational new drugs, 2010, Volume: 28, Issue:3

    Topics: Age Factors; Animals; Animals, Newborn; Anticarcinogenic Agents; Cell Line, Tumor; Cerebral Cortex; DNA; DNA Damage; DNA Repair; Drug Screening Assays, Antitumor; Glioma; Humans; In Vitro Techniques; Kinetin; Nucleic Acid Synthesis Inhibitors; Protein Kinase Inhibitors; Purines; Rats; Rats, Sprague-Dawley; Roscovitine

2010
Alphavirus M1 induces apoptosis of malignant glioma cells via downregulation and nucleolar translocation of p21WAF1/CIP1 protein.
    Cell cycle (Georgetown, Tex.), 2009, Oct-15, Volume: 8, Issue:20

    Topics: Alphavirus; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclin A; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Down-Regulation; Glioma; Phosphorylation; Proliferating Cell Nuclear Antigen; Purines; Rats; RNA, Messenger; Roscovitine; S Phase

2009
Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant glioma.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Jul-31, Volume: 109, Issue:31

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; CDC2 Protein Kinase; Cell Line, Tumor; Cyclin-Dependent Kinase 2; Female; Glioma; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Purines; Roscovitine; Xenograft Model Antitumor Assays

2012
Roscovitine sensitizes glioma cells to TRAIL-mediated apoptosis by downregulation of survivin and XIAP.
    Oncogene, 2004, Jan-15, Volume: 23, Issue:2

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Astrocytes; bcl-X Protein; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Survival; Down-Regulation; Glioma; Humans; Inhibitor of Apoptosis Proteins; Membrane Glycoproteins; Microtubule-Associated Proteins; Neoplasm Proteins; Proteins; Proto-Oncogene Proteins c-bcl-2; Purines; Roscovitine; Survivin; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; X-Linked Inhibitor of Apoptosis Protein

2004